raloxifene hydrochloride has been researched along with Acromegaly in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akbari, H; Alaei-Shahmiri, F; Asadi, P; Ghorbani, M; Honardoost, M; Imani, M; Kaynama, MR; Khamseh, ME; Malek, M | 1 |
| Attanasio, R; Barausse, M; Cozzi, R | 1 |
| Barkan, AL; Dimaraki, EV; Symons, KV | 1 |
3 trial(s) available for raloxifene hydrochloride and Acromegaly
| Article | Year |
|---|---|
COMPARISON OF CABERGOLINE VERSUS RALOXIFENE ADD-ON THERAPY TO LONG-ACTING SOMATOSTATIN ANALOGUE IN PATIENTS WITH INADEQUATELY CONTROLLED ACROMEGALY: A RANDOMIZED OPEN LABEL CLINICAL TRIAL.
Topics: Acromegaly; Adult; Blood Pressure; Cabergoline; Ergolines; Female; Human Growth Hormone; Humans; Insulin-Like Growth Factor I; Logistic Models; Male; Middle Aged; Prospective Studies; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Somatostatin | 2018 |
Raloxifene lowers IGF-I levels in acromegalic women.
Topics: Acromegaly; Aged; Aged, 80 and over; Female; Humans; Insulin-Like Growth Factor I; Middle Aged; Pilot Projects; Postmenopause; Prospective Studies; Raloxifene Hydrochloride; Retrospective Studies; Selective Estrogen Receptor Modulators | 2003 |
Raloxifene decreases serum IGF-I in male patients with active acromegaly.
Topics: Acromegaly; Adult; Estrogen Antagonists; Glucose Tolerance Test; Growth Hormone-Releasing Hormone; Human Growth Hormone; Humans; Insulin-Like Growth Factor I; Male; Middle Aged; Raloxifene Hydrochloride; Thyrotropin-Releasing Hormone | 2004 |